Evaluation and Comparison of Prognostic Multigene Tests in Early‐Stage Breast Cancer: Which Is the Most Effective? A Literature Review Exploring Clinical Utility to Enhance Therapeutic Management in Luminal Patients

Documenti analoghi

• Case report & review: Bilateral NIFTP harboring concomitant HRAS and KRAS mutation: Report of an unusual case and literature review
  di: Marianna Rita Brogna, et al.
  Pubblicazione: (2024)
• Therapeutic Suppression of Triple‐Negative Breast Cancer via Pachymic Acid‐Induced KIF18B Inhibition and Ferroptosis Activation
  di: Tao Huang, et al.
  Pubblicazione: (2025)
• The Endocrine Disrupting Compounds Bisphenol‐A and α‐Zeranol Mimic the Estrogen Transcriptional Program to Promote Proliferation and Stemness in Breast Cancer Cells
  di: Cassandra Winz, et al.
  Pubblicazione: (2026)
• Four‐gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma
  di: Zheng Gong, et al.
  Pubblicazione: (2025)
• Expression of Concern: Amplification of Cyclinl1 in Uterine Cervical Carcinoma Has Prognostic Implications
  Pubblicazione: (2025)